Logo image of EXPL.PA

EXPLOSIFS PROD. CHI (EXPL.PA) Stock Fundamental Analysis

EPA:EXPL - Euronext Paris - Matif - FR0014003AQ4 - Common Stock - Currency: EUR

208  +3 (+1.46%)

Fundamental Rating

5

EXPL gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 67 industry peers in the Chemicals industry. EXPL scores excellent on profitability, but there are some minor concerns on its financial health. EXPL has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

In the past year EXPL was profitable.
In the past year EXPL had a positive cash flow from operations.
Of the past 5 years EXPL 4 years were profitable.
In the past 5 years EXPL always reported a positive cash flow from operatings.
EXPL.PA Yearly Net Income VS EBIT VS OCF VS FCFEXPL.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M

1.2 Ratios

Looking at the Return On Assets, with a value of 4.98%, EXPL is in the better half of the industry, outperforming 73.13% of the companies in the same industry.
Looking at the Return On Equity, with a value of 14.04%, EXPL is in the better half of the industry, outperforming 79.10% of the companies in the same industry.
With a decent Return On Invested Capital value of 6.36%, EXPL is doing good in the industry, outperforming 68.66% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for EXPL is in line with the industry average of 6.29%.
The last Return On Invested Capital (6.36%) for EXPL is above the 3 year average (6.01%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 4.98%
ROE 14.04%
ROIC 6.36%
ROA(3y)4.63%
ROA(5y)2%
ROE(3y)14.6%
ROE(5y)5.29%
ROIC(3y)6.01%
ROIC(5y)4.98%
EXPL.PA Yearly ROA, ROE, ROICEXPL.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20

1.3 Margins

Looking at the Profit Margin, with a value of 4.77%, EXPL is in the better half of the industry, outperforming 65.67% of the companies in the same industry.
In the last couple of years the Profit Margin of EXPL has grown nicely.
EXPL has a Operating Margin (4.22%) which is comparable to the rest of the industry.
In the last couple of years the Operating Margin of EXPL has grown nicely.
EXPL has a better Gross Margin (60.41%) than 89.55% of its industry peers.
In the last couple of years the Gross Margin of EXPL has grown nicely.
Industry RankSector Rank
OM 4.22%
PM (TTM) 4.77%
GM 60.41%
OM growth 3Y7.17%
OM growth 5Y14.75%
PM growth 3Y45.4%
PM growth 5YN/A
GM growth 3Y0.5%
GM growth 5Y11.18%
EXPL.PA Yearly Profit, Operating, Gross MarginsEXPL.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

4

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so EXPL is destroying value.
EXPL has more shares outstanding than it did 1 year ago.
EXPL has more shares outstanding than it did 5 years ago.
The debt/assets ratio for EXPL has been reduced compared to a year ago.
EXPL.PA Yearly Shares OutstandingEXPL.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M 2M
EXPL.PA Yearly Total Debt VS Total AssetsEXPL.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.2 Solvency

An Altman-Z score of 2.71 indicates that EXPL is not a great score, but indicates only limited risk for bankruptcy at the moment.
EXPL's Altman-Z score of 2.71 is fine compared to the rest of the industry. EXPL outperforms 67.16% of its industry peers.
EXPL has a debt to FCF ratio of 2.38. This is a good value and a sign of high solvency as EXPL would need 2.38 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 2.38, EXPL belongs to the top of the industry, outperforming 91.04% of the companies in the same industry.
A Debt/Equity ratio of 0.40 indicates that EXPL is not too dependend on debt financing.
EXPL has a Debt to Equity ratio (0.40) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.4
Debt/FCF 2.38
Altman-Z 2.71
ROIC/WACC0.86
WACC7.41%
EXPL.PA Yearly LT Debt VS Equity VS FCFEXPL.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M

2.3 Liquidity

EXPL has a Current Ratio of 1.26. This is a normal value and indicates that EXPL is financially healthy and should not expect problems in meeting its short term obligations.
EXPL has a Current ratio of 1.26. This is in the lower half of the industry: EXPL underperforms 77.61% of its industry peers.
EXPL has a Quick Ratio of 1.26. This is a bad value and indicates that EXPL is not financially healthy enough and could expect problems in meeting its short term obligations.
EXPL has a worse Quick ratio (0.94) than 64.18% of its industry peers.
Industry RankSector Rank
Current Ratio 1.26
Quick Ratio 0.94
EXPL.PA Yearly Current Assets VS Current LiabilitesEXPL.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 8.64% over the past year.
EXPL shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 51.47% yearly.
Looking at the last year, EXPL shows a small growth in Revenue. The Revenue has grown by 1.64% in the last year.
Measured over the past years, EXPL shows a small growth in Revenue. The Revenue has been growing by 7.27% on average per year.
EPS 1Y (TTM)8.64%
EPS 3Y51.47%
EPS 5YN/A
EPS Q2Q%21.81%
Revenue 1Y (TTM)1.64%
Revenue growth 3Y9.08%
Revenue growth 5Y7.27%
Sales Q2Q%3.44%

3.2 Future

The Earnings Per Share is expected to grow by 17.28% on average over the next years. This is quite good.
The Revenue is expected to grow by 3.63% on average over the next years.
EPS Next Y19.38%
EPS Next 2Y21.01%
EPS Next 3Y17.28%
EPS Next 5YN/A
Revenue Next Year3.21%
Revenue Next 2Y4.19%
Revenue Next 3Y3.63%
Revenue Next 5YN/A

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
EXPL.PA Yearly Revenue VS EstimatesEXPL.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M 400M 500M
EXPL.PA Yearly EPS VS EstimatesEXPL.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 5 10 15

6

4. Valuation

4.1 Price/Earnings Ratio

EXPL is valuated rather expensively with a Price/Earnings ratio of 18.84.
EXPL's Price/Earnings ratio is a bit cheaper when compared to the industry. EXPL is cheaper than 62.69% of the companies in the same industry.
EXPL's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.51.
The Price/Forward Earnings ratio is 14.21, which indicates a correct valuation of EXPL.
Based on the Price/Forward Earnings ratio, EXPL is valued a bit cheaper than 65.67% of the companies in the same industry.
EXPL's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 35.58.
Industry RankSector Rank
PE 18.84
Fwd PE 14.21
EXPL.PA Price Earnings VS Forward Price EarningsEXPL.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

EXPL's Enterprise Value to EBITDA is on the same level as the industry average.
Based on the Price/Free Cash Flow ratio, EXPL is valued cheaply inside the industry as 85.07% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 11.58
EV/EBITDA 11.17
EXPL.PA Per share dataEXPL.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 50 100 150 200

4.3 Compensation for Growth

EXPL's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
EXPL has a very decent profitability rating, which may justify a higher PE ratio.
EXPL's earnings are expected to grow with 17.28% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.97
PEG (5Y)N/A
EPS Next 2Y21.01%
EPS Next 3Y17.28%

2

5. Dividend

5.1 Amount

EXPL has a yearly dividend return of 0.74%, which is pretty low.
EXPL's Dividend Yield is slightly below the industry average, which is at 2.99.
Compared to an average S&P500 Dividend Yield of 2.35, EXPL's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.74%

5.2 History

The dividend of EXPL decreases each year by -6.39%.
Dividend Growth(5Y)-6.39%
Div Incr Years1
Div Non Decr Years1
EXPL.PA Yearly Dividends per shareEXPL.PA Yearly Dividends per shareYearly Dividends per share 2019 2024 2025 0.5 1

5.3 Sustainability

EXPL pays out 9.03% of its income as dividend. This is a sustainable payout ratio.
DP9.03%
EPS Next 2Y21.01%
EPS Next 3Y17.28%
EXPL.PA Yearly Income VS Free CF VS DividendEXPL.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M 30M 40M
EXPL.PA Dividend Payout.EXPL.PA Dividend Payout, showing the Payout Ratio.EXPL.PA Dividend Payout.PayoutRetained Earnings

EXPLOSIFS PROD. CHI

EPA:EXPL (7/15/2025, 9:41:22 AM)

208

+3 (+1.46%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners3.7%
Inst Owner ChangeN/A
Ins Owners10.85%
Ins Owner ChangeN/A
Market Cap470.08M
Analysts42.22
Price Target221.34 (6.41%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.74%
Yearly Dividend1
Dividend Growth(5Y)-6.39%
DP9.03%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0.77%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.5%
Valuation
Industry RankSector Rank
PE 18.84
Fwd PE 14.21
P/S 0.96
P/FCF 11.58
P/OCF 7.01
P/B 2.82
P/tB 3.14
EV/EBITDA 11.17
EPS(TTM)11.04
EY5.31%
EPS(NY)14.64
Fwd EY7.04%
FCF(TTM)17.96
FCFY8.64%
OCF(TTM)29.69
OCFY14.27%
SpS216.88
BVpS73.67
TBVpS66.32
PEG (NY)0.97
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 4.98%
ROE 14.04%
ROCE 7.48%
ROIC 6.36%
ROICexc 6.41%
ROICexgc 6.82%
OM 4.22%
PM (TTM) 4.77%
GM 60.41%
FCFM 8.28%
ROA(3y)4.63%
ROA(5y)2%
ROE(3y)14.6%
ROE(5y)5.29%
ROIC(3y)6.01%
ROIC(5y)4.98%
ROICexc(3y)6.49%
ROICexc(5y)5.43%
ROICexgc(3y)6.91%
ROICexgc(5y)5.79%
ROCE(3y)7.04%
ROCE(5y)5.85%
ROICexcg growth 3Y2.1%
ROICexcg growth 5Y14.44%
ROICexc growth 3Y2.48%
ROICexc growth 5Y15.88%
OM growth 3Y7.17%
OM growth 5Y14.75%
PM growth 3Y45.4%
PM growth 5YN/A
GM growth 3Y0.5%
GM growth 5Y11.18%
F-Score6
Asset Turnover1.04
Health
Industry RankSector Rank
Debt/Equity 0.4
Debt/FCF 2.38
Debt/EBITDA 1.33
Cap/Depr 91.37%
Cap/Sales 5.41%
Interest Coverage 3.37
Cash Conversion 135.01%
Profit Quality 173.71%
Current Ratio 1.26
Quick Ratio 0.94
Altman-Z 2.71
F-Score6
WACC7.41%
ROIC/WACC0.86
Cap/Depr(3y)105.91%
Cap/Depr(5y)86.48%
Cap/Sales(3y)5.43%
Cap/Sales(5y)5.08%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)8.64%
EPS 3Y51.47%
EPS 5YN/A
EPS Q2Q%21.81%
EPS Next Y19.38%
EPS Next 2Y21.01%
EPS Next 3Y17.28%
EPS Next 5YN/A
Revenue 1Y (TTM)1.64%
Revenue growth 3Y9.08%
Revenue growth 5Y7.27%
Sales Q2Q%3.44%
Revenue Next Year3.21%
Revenue Next 2Y4.19%
Revenue Next 3Y3.63%
Revenue Next 5YN/A
EBIT growth 1Y22.43%
EBIT growth 3Y16.9%
EBIT growth 5Y23.09%
EBIT Next Year87.74%
EBIT Next 3Y32.42%
EBIT Next 5YN/A
FCF growth 1Y284.59%
FCF growth 3Y49.53%
FCF growth 5Y77.86%
OCF growth 1Y102.52%
OCF growth 3Y33.74%
OCF growth 5Y25.45%